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Introduction {#s1}
============

Intrauterine growth restriction (IUGR) is an adverse pregnancy outcome defined by Peleg et al. ([@c43]) as a reduction in fetal weight (below the 10th percentile for gestational age) with an abdominal circumference below the 2.5th percentile, although inconsistencies in the definition of IUGR exist. IUGR affects 5.8--11.2% of all pregnancies in the United States, varying by ethnicity ([@c25]), and 23.8% of pregnancies in developing countries ([@c12]). Growth-compromised offspring have increased risk of perinatal death ([@c5]) and of later-in-life adverse health outcomes including neurodevelopmental delay ([@c37]) and cardiometabolic diseases ([@c10]). The pathogenesis of IUGR is complex and incompletely understood ([@c49]), and effective prevention recommendations and treatment options are currently limited.

Known risk factors for IUGR include, but are not limited to, poor maternal nutrition, infection, gestational hypertension (preeclampsia), and diabetes ([@c1]). With regard to air pollutants, studies have found relationships between prenatal ozone exposure and reduced birth weight ([@c57]). More specifically, Tu et al. ([@c51]) reported that ambient ozone was inversely associated with term birth weight among 105,818 singleton births in the state of Georgia. Similarly, a study in 3,545,177 singleton births in California also demonstrated an inverse relationship with ozone exposure and birth weight ([@c35]). In contrast, others have not found associations between ozone exposure during pregnancy and fetal weight. For example, Liu et al. ([@c28]) failed to find a positive association between IUGR and gestational ozone exposure in Canadian singleton births between 1986 and 2000; Gouveia et al. ([@c17]) also did not find a relationship between ozone exposure and low birth weight in 213,973 births in São Paulo, Brazil. Inconsistent findings among observational studies may be related to differences in seasonal temperature or to variability in sensitivity at different stages of gestation. Arroyo et al. ([@c3]) reported a positive relationship between second-trimester ambient temperature and low birth weight, as well as a similar relationship between first-trimester ozone exposure and birth weight in all singleton births in Madrid, Spain between 2001 and 2009. Additionally, Geer et al. ([@c16]) reported that estimated ozone exposure during the first and second trimesters was associated with lower term birth weight among $> 1,500,000$ births in Texas between 1998 and 2004. Further, among California participants in the Children's Health Study, positive associations between ozone and IUGR were reported for exposures during both the second and third trimesters ([@c48]). Thus, the influence of the period during gestation in which exposure to ozone takes place requires further study.

Adverse pregnancy outcomes such as IUGR may initiate from suboptimal implantation in the uterine wall \[reviewed by Young et al. ([@c56])\]. It is hypothesized that disrupted stem cell invasion may lead to poor spiral and uterine artery remodeling with subsequent impaired placental development. In turn, the stress from diminished uterine arterial blood flow and insufficient placental nutrition may result in maternal systemic endothelial dysfunction and inflammation, hypertension, and kidney injury related to glomerular damage. Poor arterial remodeling also impairs fetal blood flow, which may promote disrupted placental development and decreased fetal weight gain.

Given this evidence, we hypothesized that ozone exposure exclusively during the period of implantation receptivity in the rat would compromise fetal growth and maternal health in late gestation. Anticipating that impairments in fetal growth may be related to diminished uterine arterial flow, we used Doppler ultrasonography periodically throughout gestation to assess changes in uterine artery blood flow. The duration of implantation receptivity in rats and humans is similar (2 d). Thus, investigating the effects of ozone exposure during the time of implantation may provide a plausible mechanism that links gestational ozone exposure and IUGR.

Methods {#s2}
=======

Rats and Experimental Design {#s2.1}
----------------------------

Timed-pregnant Long-Evans female rats ($n = 10/\text{group}$) from Charles River Laboratories were transferred to the U.S. Environmental Protection Agency (EPA) animal facility on gestation day (GD) 1 (plug-positive day). All procedures involving animals were approved by the Institutional Animal Care and Use Committee at the National Health and Environmental Effects Research Laboratory, an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited facility. All animals were treated humanely and with regard for alleviation of suffering. A modified, phytoestrogen-free American Institute of Nutrition growth and lactation diet (D15092401; Research Diets) was provided *ad libitum* to dams after arrival. Food intake and body weight were measured daily. The primary caretaker was blinded to the exposure groups throughout the study.

Rats were randomly assigned to one of three groups: filtered air, $0.4\,\text{ppm}$ ozone, or $0.8\,\text{ppm}$ ozone. These concentrations were selected based on evidence that there is a four- to five-fold difference in relative lung ozone dosimetry between resting rats and humans exercising heavily on an intermittent basis, as determined by heavy (^18^O-labeled) reaction product concentrations in the lung ([@c21]). Thus, the 0.4 and $0.8\,\text{ppm}$ concentrations in rats correspond approximately to 0.08 and $0.16\,\text{ppm}$ exposure concentrations, respectively, in humans. The approved 2015 U.S. national ambient air quality standard (NAAQS) for ozone is $0.070\,\text{ppm}$, with an 8-h averaging time ([@c13]).

On GD 5 and 6, rats were exposed for 4 h (0700--1100 hours) in Rochester-style "Hinners" chambers that were controlled for temperature ($22.5 \pm 0.14{^\circ}C$) and humidity ($50.0 \pm 0.65\%$). Ozone was generated in a silent arc discharge generator (OREC™) and was pumped into the chambers using a mass flow controller. Concentrations were recorded throughout the exposure using an ozone analyzer (API Model 400; Teledyne Instruments). To quantify the extent of ozone-induced ventilatory dysfunction (which has not been previously reported in pregnant Long-Evans rats), conscious, unrestrained rats were placed in whole-body plethysmographs immediately following exposure. Estimates of tidal volume, breathing frequency, minute volume, peak flow rates, and enhanced pause \[Penh; an index of airflow limitation and a surrogate measure for bronchoconstriction ([@c18])\] were obtained using emka iox2 software (emka TECHNOLOGIES).

On GD 15, 19, and 21, blood pressure was measured using tail cuff photoplethysmography. Rats were acclimated to a plexiglass restraint tube for 5 min at 22.2--23.3°C and then for 5 min in a prewarmed 32°C chamber. Tail blood pressure was determined from 3--5 readings of each rat on an IITC Life Science Inc. system and was analyzed using Model 31 NIBP software (v.1.32; IITC Life Science Inc.).

Uterine Artery Blood Flow {#s2.2}
-------------------------

Because blood flow through the uterine artery does not increase until GD 14 ([@c40]), we assessed uterine arterial blood flow after that time point. On GD 15, 19, and 21, pulsed-wave Doppler ultrasonography (Vevo 2100 Imaging System; FUJIFILM VisualSonics Inc.) was performed to evaluate blood flow in the left uterine artery, similar to procedures that have been described previously ([@c44]). In brief, rats were anesthetized with 3% isoflurane and were maintained at 1.5% with a targeted heart rate range of 400--450 beats per minute. Dams were placed in dorsal recumbency on a heated monitoring platform (FUJIFILM VisualSonics Inc.), which allowed monitoring of heart rate and electrocardiogram (ECG) traces, respiration rate, and body temperature. Fur was clipped from the abdomen, and a depilatory agent was used to remove any remaining fur. Pulsed-wave Doppler ultrasonography was performed using a 12.5-MHz MS201 transducer (FUJIFILM VisualSonics Inc.). All measurements and analyses were performed using Vevo LAB software (v.1.7, FUJIFILM VisualSonics Inc.) by researchers who were blinded to the experimental groups. Data were derived by analyzing six arterial pulsatile blood flow waveforms from each dam at each time point. Peak systolic velocity (PSV) was measured at the point of peak velocity, and end diastolic velocity (EDV) was marked at the next ECG R-wave after PSV was measured ([Figure 1](#f1){ref-type="fig"}). Markers of resistance were calculated using the following formulas: $\text{resistance}\,\text{index} = \left( {\text{PSV} - \text{EDV}} \right)/\text{PSV}$; $\text{pulsatility}\,\text{index} = \left( {\text{PSV} - \text{EDV}} \right)/\text{mean}\,\text{blood}\,\text{velocity}\,\left( \text{mV} \right)$; and $\text{systole}/\text{diastole}\,\left( {S/D} \right)\,\text{ratio} = \left( {\text{PSV}/\text{EDV}} \right)$.

![Equations of the resistance indices in Doppler ultrasonography. Resistance in the artery can be measured through resistance index (RI) \[peak systolic velocity (PSV) -- end diastolic velocity (EDV)/(PSV)\], systolic/diastolic (S/D) ratio (PSV/EDV), and the pulsatility index (PI) \[(PSV -- EDV)/mean blood velocity (mV)\].](EHP2019_f1){#f1}

Necropsy and Tissue Collection {#s2.3}
------------------------------

On GD 21, dams were euthanized with a lethal intraperitoneal dose of pentobarbital ($> 400\;{mg}/{kg}$) following a 5 h fast; this dose also euthanized the fetuses *in utero*. Whole blood was obtained from the abdominal aorta and was collected into serum separator tubes and ethylenediamine tetraacetic acid (EDTA) tubes for plasma collection. Following centrifugation for 10 min at $2,465\;\times\; g$ and 4°C, aliquots were prepared from the resulting supernatant and were stored at $- 80ºC$ until use. Bronchoalveolar lavage fluid (BALF) was collected and analyzed from dams as previously described ([@c54]). Briefly, the following markers of pulmonary injury were assessed: total protein ($\mu g/{mL}$ BALF), albumin ($\mu g/{mL}$ BALF), lactate dehydrogenase (LDH) activity \[U/L (units per liter) BALF\], *N*-acetyl glucosaminidase (NAG) activity (U/L BALF), and $\gamma - \text{glutamyl}$ transferase (GGT) activity (U/L BALF). The following markers of pulmonary inflammation were assessed: alveolar macrophages, eosinophils, lymphocytes, and neutrophils. The right kidney was collected, divided midsagittally, placed in Bodian's fixative (2% formaldehyde, 5% acetic acid, 72% ethanol, and 21% water), and stored at 4°C for histopathology. The gravid uterus was weighed and assessed for implantation sites. Fetuses were counted and assessed for crown-rump length, weight, and sex. Ultimately, one dam from the air group and one dam from the $0.4\,\text{ppm}$ ozone--exposed group were removed from the study at the time of necropsy owing to insufficient litter size ($n < 5\,\text{fetuses}$). Excessively small litters reduce maternal nutritional requirements ([@c30]) and promote larger fetal size because of reduced competition for nutrients within the litter ([@c47]).

Circulating Metabolic Markers {#s2.4}
-----------------------------

Serum norepinephrine was measured using a Norepinehprine Research ELISA kit (Rocky Mountain Diagnostics, Inc.), and corticosterone was measured using an enzyme immunoassay kit (Arbor Assays) according to the manufacturers' protocols. Serum glucose was measured using a Glucose (oxidase) Reagent set, total cholesterol was measured using an Enzymatic Liquid kit, and triglycerides were measured using a GPO Trinder kit (all from TECO Diagnostics). High-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol were measured using automated reagents (Sekisui Diagnostics). Serum free fatty acids (FFAs) were measured using a colorimetric assay (Cell Biolabs, Inc.). The cholesterol and FFA assays were modified for use on a Konelab Arena 30 system (Thermo LabSystems Inc.). Plasma insulin was detected using a Rat/Mouse Insulin ELISA (Millipore), and branched chain amino acid plasma levels were detected using a Branched Chain Amino Acid Assay kit (Abcam).

Inflammatory Measurements {#s2.5}
-------------------------

Preeclampsia is associated with increased serum inflammatory status in the mother ([@c33]). Hence, inflammation markers were measured in maternal serum using a Meso Scale Proinflammatory Panel 2 kit for rats on a Meso Scale QuickPlex SQ 120 system (Meso Scale Diagnostics, LLC). This predesigned kit provided a broad spectrum of proinflammatory cytokines in a multiplexed assay including $\text{interferon} - \gamma$ ($\text{IFN}\gamma$), $\text{interleukin} - 1\beta$ ($\text{IL}1\beta$), interleukin 4 (IL4), interleukin 5 (IL5), interleukin 6 (IL6), interleukin 10 (IL10), interleukin 13 (IL13), keratinocyte chemoattractant/human growth-regulated oncogene (KC-GRO), and tumor necrosis $\text{factor} - \alpha$ ($\text{TNF}\alpha$). Assay was performed according to the manufacturer's protocols.

Histopathology {#s2.6}
--------------

After fixation, right kidneys were embedded in paraffin wax and sectioned at $5\;\mu m$. Kidney sections were deparaffinized and stained with hematoxylin and eosin (H&E) (BBC Biochemical) using standard procedures and were evaluated via light microscopy by a certified study pathologist (C.E.W.). According to best practices for nonclinical safety studies ([@c11]), primary histopathological review was performed unblinded to experimental treatment, and findings that might have been treatment-related or might otherwise have affected interpretation were re-reviewed in a blinded manner to confirm differences from controls, severity grade, or both. Histopathological diagnoses were based on standard criteria and nomenclature ([@c15]). Severity of lesions was qualitatively graded using a 0--4 scale ($0 = \text{absent}$, $1 = \text{minimal}$, $2 = \text{mild}$, $3 = \text{moderate}$, $4 = \text{severe}$) based on increasing extent, complexity of change, or a combination of the two.

Fetal Body Composition Measurements {#s2.7}
-----------------------------------

At necropsy, three arbitrarily selected fetuses from each sex were grouped from each dam and were stored at 4°C. If there was an insufficient number of fetuses, a measurement could not be obtained. Hence, an $n = 7/\text{litter}$ group was analyzed for air and for $0.8\,\text{ppm}$ ozone, whereas an $n = 8/\text{litter}$ group was analyzed for $0.4\,\text{ppm}$ ozone. After warming to room temperature (22.2--23.3°C), body composition (grams of fat and lean body mass) was measured using magnetic resonance on the $n = 3$ representative grouping for each litter (measured at the same time) using an EchoMRI™-100 system (EchoMRI™) at the University of North Carolina at Chapel Hill Nutrition Obesity Research Center.

Statistics {#s2.8}
----------

For fetal growth metrics, all analyses were performed separately by sex, and litters were pooled by sex. Data were analyzed using a two-tailed Fisher's least significant difference (LSD) test for all planned multiple comparisons (filtered air vs. $0.4\,\text{ppm}$ vs. $0.8\,\text{ppm}$ ozone for all data) within a one-way analysis of variance (ANOVA) (GraphPad Prism v.6; GraphPad Software, Inc.). Fisher's LSD test does not correct for multiple comparisons; however, it can be used in study designs with three groups without increasing Type I error rate ([@c29]). Upon determining that fetal weight was reduced in fetuses from ozone-exposed pregnancies, *a priori* body composition measurements were performed. Therefore, a one-tailed Fisher's LSD test within a one-way ANOVA was used to assess differences in fetal body composition. Finally, because renal pathology findings were only assessed in the positive direction (i.e., increasing pathological changes), histopathology incidence data were analyzed using a one-sided Fisher's exact test. For all measurements, significance was set at $p < 0.05$.

Results {#s3}
=======

Effects of Ozone Exposure during Implantation on Dams {#s3.1}
-----------------------------------------------------

Food intake and body weight were monitored throughout gestation as markers of growth and overall maternal health. Because the size of the litter affects the nutrient demands of the pregnant rodent ([@c30]), the two dams having litters with $< 5$ fetuses (one from the air group and one from the $0.4\,\text{ppm}$ ozone group) were removed from all analyses in the study. Exposure to $0.8\,\text{ppm}$ ozone reduced 48 h body weight gain and food intake in pregnant dams over the exposure period (difference between GD 5 and GD 7) ([Figure 2A](#f2){ref-type="fig"}, [B](#f2){ref-type="fig"}). There were no significant differences between treatment groups in total weight gain or in food intake during pregnancy ([Table 1](#t1){ref-type="table"}).

![Average maternal body weight, food intake, and respiratory parameters following ozone exposure ($0.4\,\text{ppm}$, $n = 9$, or $0.8\,\text{ppm}$, $n = 10$) or air exposure ($n = 9$). (*A*) Mean body weight (g) according to treatment group and gestational day (GD), with the insert showing the mean weight gain over 48 h (from GD 5 to GD 7). (*B*) Mean food intake (g) according to treatment group and GD. (*C*) Mean enhanced pause (Penh) according to treatment group on GD 5, 6, 15, 19, and 21. (*D*) Mean minute volume (mL/min) according to treatment group (GD 5, 6, 15, 19, and 21). Error bars indicate the standard error. Data were analyzed by two-tailed Fisher's least significant difference (LSD) posttest within a one-way analysis of variance (ANOVA). \* $p < 0.05$, \*\*\* $p < 0.001$, \*\*\*\* $p < 0.0001$ versus air controls; \# $p < 0.05$, $0.4\,\text{ppm}$ versus $0.8\,\text{ppm}$ ozone.](EHP2019_f2){#f2}

###### 

Litter characteristics according to exposure group \[$\text{mean} \pm \text{standard}\,\text{error}\,\text{of}\,\text{the}\,\text{mean}\,\left( \text{SE} \right)$\].

Table 1 lists characteristics in the first column; the corresponding values for air, 0.4 parts per million, 0.8 parts per million, and ANOVA p values are listed in the other columns.

  Characteristics                               Air[^*a*^](#t1n1){ref-type="table-fn"}   $0.4\,\text{ppm}$[^*a*^](#t1n1){ref-type="table-fn"}   $0.8\,\text{ppm}$   ANOVA *p*-value[^*b*^](#t1n2){ref-type="table-fn"} (totals)
  --------------------------------------------- ---------------------------------------- ------------------------------------------------------ ------------------- -------------------------------------------------------------
  Total number of litters maintained to GD 21   9                                        9                                                      10                  ---
  Gestational weight gain (g)                   $152.4 \pm 5.83$                         $147.6 \pm 5.91$                                       $139.6 \pm 6.81$    0.35
  Gestational food intake (g)                   $521.6 \pm 15.8$                         $492.9 \pm 18.4$                                       $503.2 \pm 16.8$    0.50
  Implantation sites per litter                 $13.5 \pm 0.64$                          $14.1 \pm 0.59$                                        $13.2 \pm 0.57$     0.57
  Resorptions per litter                        $1.4 \pm 0.31$                           $2.1 \pm 0.77$                                         $1.5 \pm 0.50$      0.62
  Full term fetuses                             $12.1 \pm 0.50$                          $12.0 \pm 0.37$                                        $11.7 \pm 0.72$     0.87
  Percent males per litter                      $47.0 \pm 3.95\%$                        $50.6 \pm 4.55\%$                                      $50.4 \pm 5.24\%$   0.85

Note: ANOVA, analysis of variance; GD, gestational day.

Owing to low litter size ($< 5$ fetuses), one rat each was removed from the air and the $0.4\,\text{ppm}$ group data sets.

Data were analyzed by two-tailed Fisher's least significant difference (LSD) posttest within a one-way ANOVA.

Whole-body plethysmography assessments performed immediately after ozone exposure on GD 5 and 6 and assessments of controls were performed at the same time of day. Penh, an index of airway resistance, was significantly higher in the $0.8\,\text{ppm}$ ozone group than in controls on both days and in the $0.4\,\text{ppm}$ ozone group on GD 5 ([Figure 2C](#f2){ref-type="fig"}), whereas minute volume was significantly lower in the $0.8\,\text{ppm}$ ozone group compared with controls on GD 6 ([Figure 2D](#f2){ref-type="fig"}). However, both Penh and minute volumes were comparable among controls and both exposure groups on GD 15, 19, and 21. Therefore, exposure to ozone did not appear to have lasting effects on respiratory parameters after GD 15.

Ultrasonography of Uterine Arterial Blood Flow {#s3.2}
----------------------------------------------

We used Doppler ultrasonography to assess the effects of ozone exposure during implantation on maternal uterine artery blood flow at various points during gestation. In a normal pregnancy, resistance to blood flow decreases in the uterine artery, which facilitates perfusion of the fetoplacental unit ([@c36]). In air-exposed dams, mean uterine arterial resistance \[represented by the resistance index (RI)\] decreased $3.3\%$ ($\pm 2.8\%$) from GD 15 and 21, and mV increased 4.6% ($\pm 8.6\%$) ([Figure 3B](#f3){ref-type="fig"}, [E](#f3){ref-type="fig"}; see also Table S1). The mean RI for $0.8\,\text{ppm}$ ozone--exposed dams was slightly lower than that of controls on GD 15 ($0.59 \pm 0.01$ vs. $0.61 \pm 0.01$, respectively) but was comparable to that of controls on GD 21 (both 0.60), resulting in a 2.2% increase ($\pm 2.1\%$, $p < 0.10$) from GD 15 and GD 21, in contrast to a 3.3% decrease ($\pm 2.8\%$) in the controls over the same time period. Patterns were similar for the systolic/diastolic (S/D) ratio and the pulsatility index (PI) ([Figure 3C](#f3){ref-type="fig"}, [D](#f3){ref-type="fig"}; see also Table S1), which are additional indicators of resistance. The average mV was significantly higher in $0.8\,\text{ppm}$ ozone--exposed dams than in controls on GD 15, and although it decreased from GD 15 to GD 21 ($23\% \pm 9.2\%$), there was no significant difference in the average mV between $0.8\,\text{ppm}$ dams and controls on GD 21 ([Figure 3E](#f3){ref-type="fig"}; see also Table S1).

![Percent difference in uterine artery flow metrics measured on gestational day (GD) 15 to GD 21 in dams exposed to air ($n = 9$), to $0.4\,\text{ppm}$ ozone ($n = 9$), or to $0.8\,\text{ppm}$ ozone ($n = 10$) on GD 5 and GD 6. (*A*) An example of a representative Doppler ultrasound waveform for uterine artery flow on GD 21 and shows that measures of resistance \[resistance index (RI), systolic/diastolic (S/D) ratio, and pulsatility index (PI)\] from Doppler ultrasound are performed by quantifying the relative distance between systole (S) and diastole (D); increased distance between S and D indicates increased resistance. (*B*--*E*) The percentage difference between GD 15 and GD 21 in the RI, S/D ratio, PI, and mean blood velocity (mV), respectively (see Table S1 for corresponding numeric data). Data analyzed by two-tailed Fisher's least significant difference (LSD) posttest within a one-way analysis of variance (ANOVA). Boxes extend from the 25th to the 75th percentile, horizontal bars represent the median, whiskers indicate the 10th and 90th percentiles, and outliers are represented as points. Values for individual dams are overlaid on each plot. \# $p < 0.10$ and \* $p < 0.05$ versus air controls.](EHP2019_f3){#f3}

Effects of Peri-implantation Ozone Exposure on Maternal Health in Late Gestation {#s3.3}
--------------------------------------------------------------------------------

Early gestational ozone exposure did not significantly alter blood pressure, as measured using a tail cuff, in later pregnancy (GD 15, 19, and 21; see Figure S1). No significant group differences in kidney histopathology were observable by light microscopy (see Table S2).

Examination of a panel of nine proinflammatory cytokines in the serum of dams on GD 21 revealed no significant differences among the control and treatment groups (see Table S3). In addition, there were no significant differences among groups in BALF cell counts (alveolar macrophages or other leukocytes) or in protein concentrations in BALF collected on GD 21 (see Table S4). BALF concentrations of GGT and NAG were significantly higher in $0.4\,\text{ppm}$ ozone--exposed dams than in controls, but concentrations in BALF from $0.8\,\text{ppm}$ dams were not significantly different from those in controls.

Effects of Peri-implantation Exposure to Ozone on Developmental End Points {#s3.4}
--------------------------------------------------------------------------

All dams successfully maintained their pregnancies to GD 21. After excluding one dam from the control group and one from the $0.4\,\text{ppm}$ ozone group that each had $< 5$ fetuses per litter, there were no significant differences among the treatment groups with regard to implantation sites or resorptions on GD 21, or with regard to the sex distribution of the fetuses ([Table 1](#t1){ref-type="table"}).

There were no significant differences among treatment groups in the average length of male and female fetuses from each litter on GD 21 ([Figure 4A](#f4){ref-type="fig"} and [B](#f4){ref-type="fig"}, respectively). However, average weights of fetuses in each litter were lower in the litters exposed to $0.4\,\text{ppm}$ and $0.8\,\text{ppm}$ ozone on GD 5 and 6 compared with controls (significant for males in both exposed groups and for females in the $0.8\,\text{ppm}$ group). Reduced fetal weight with normal fetal length is consistent with asymmetrical IUGR, which is purportedly related to reduced fetal nutrition and oxygen supply in the second half of pregnancy ([@c34]); this is in contrast with symmetrical IUGR, in which both weight and length are reduced owing to poor cellular development in the first trimester, the second trimester, or in both ([@c6]).

![Body size measurements in male and female offspring on gestational day (GD) 21 according to treatment group and sex. (*A*) and (*B*) Distribution of litter average values for length (cm) and weight (g) in males and females, respectively, from each litter ($n = 9$, 9, and $10\,\text{litters}$ for air, $0.4\,\text{ppm}$ ozone, and $0.8\,\text{ppm}$ ozone groups, respectively). (*C*) and (*D*) Distribution of litter average values for fat mass and lean mass (relative to controls) in males and females, respectively ($n = 3$ fetuses pooled per litter for each group and sex; $n = 7$, 8, and 7 litters for air, $0.4\,\text{ppm}$ ozone, and $0.8\,\text{ppm}$ ozone groups, respectively). (*E*) and (*F*) Distribution of litter average values for fat mass to lean mass ratio in males and females, respectively (calculated by the obtained fat and lean mass for the $n = 3$ fetuses pooled per litter for each group and sex; $n = 7$, 8, and 7 litters for air, $0.4\,\text{ppm}$ ozone, and $0.8\,\text{ppm}$ ozone groups, respectively). The data were analyzed by one-way analysis of variance (ANOVA) within a two-tailed Fisher's least significant difference (LSD) posttest (for length and weight) or a one-tailed Fisher's LSD posttest (for fat mass, lean mass, and fat-to-lean mass ratios). Boxes extend from the 25th to the 75th percentile, horizontal bars represent the median, whiskers indicate the 10th and 90th percentiles, and outliers are represented as points. Average values for individual litters (by sex) are overlaid on each plot. \# $p < 0.10$, \* $p < 0.05$, \*\* $p < 0.01$ versus air controls.](EHP2019_f4){#f4}

Because asymmetrical IUGR is associated with reduced adipose tissue deposition due to decreased nutritional supply in the second half of pregnancy ([@c26]), we next investigated the potential influence of ozone-induced growth restriction on the body composition of the offspring. Average litter values for lean mass and fat mass (based on pooled data for 3 randomly selected male and female fetuses from each litter) were lower in the ozone-exposed litters ($n = 8$ for $0.4\,\text{ppm}$, $n = 7$ for $0.8\,\text{ppm}$) than in controls ($n = 7$), with significant differences from controls (based on the one-tailed Fisher's LSD posttest) in the $0.8\,\text{ppm}$ groups for both outcomes in both male and female fetuses ([Figure 4C](#f4){ref-type="fig"}, [D](#f4){ref-type="fig"}). The ratio of fat mass--to--lean body mass \[fat mass (g)/lean body mass (g) of the pooled group for each litter, separated by sex\] was then assessed because asymmetrical IUGR is related to reduced fat development *in utero* ([@c26]), and the ratio provides an estimate of relative adiposity. Although the fat-to-lean mass ratio was not statistically different (based on the one-tailed Fisher's LSD posttest) in female offspring from ozone-exposed pregnancies, male offspring from $0.8\,\text{ppm}$ ozone--exposed dams had a modest, nonstatistically significant reduction in fat mass relative to lean mass ($p = 0.06$; [Figure 4E](#f4){ref-type="fig"}, [F](#f4){ref-type="fig"}).

Mean serum FFAs on GD 21 were significantly higher in dams exposed to either concentration of ozone than in air controls ([Figure 5A](#f5){ref-type="fig"}), whereas mean blood glucose concentrations were significantly lower in ozone-exposed dams ([Figure 5B](#f5){ref-type="fig"}). There were no significant differences in other maternal serum parameters on GD 21, including insulin and triglycerides, among the treatment groups (see Table S5).

![Serum free fatty acids (*A*) and blood glucose (*B*) on gestational day (GD 21) dams exposed to air ($n = 9$), $0.4\,\text{ppm}$ ozone ($n = 9$), or $0.8\,\text{ppm}$ ozone ($n = 10$) on GD 5 and GD 6. The data were analyzed by two-tailed Fisher's least significant difference (LSD) posttest within a one-way analysis of variance (ANOVA). Boxes extend from the 25th to the 75th percentile, horizontal bars represent the median, whiskers indicate the 10th and 90th percentiles, and outliers are represented as points. Values for individual dams are overlaid on each plot. \* $p < 0.05$, \*\* $p < 0.01$ versus air controls.](EHP2019_f5){#f5}

Discussion {#s4}
==========

In this study, the offspring of Long-Evans rats with acute ozone exposure exclusively during the period of implantation receptivity had lower average fetal weight on GD 21 than air-exposed controls. Although most measures of maternal health at the end of gestation were not significantly different among treatment groups, uterine arterial resistance appeared to in-crease between GD 15 and GD 21 among dams in the high ozone--exposure group, and it appeared to decrease between GD 15 and GD 21 among dams in the control and low ozone--exposure groups, although this decrease was greater in controls. These findings suggest a relationship between maternal blood flow and fetal growth in this model. The differences in fetal body composition and in serum glucose and fatty acids in exposed dams versus controls that we observed in the present study are consistent with findings from two small case--control studies of IUGR in Italian women ([@c2]; [@c27]), and they support our hypothesis that peri-implantation exposure to ozone impairs fetal growth.

Doppler ultrasonography is used to monitor uterine artery blood flow during gestation and to identify high-risk pregnancies and facilitate rapid intervention in emergency situations ([@c20]; [@c50]). We used ultrasonography to monitor arterial health *in vivo* as a potential mechanism for the development of growth restriction. All ultrasound examiners were blinded to the treatment status of the dams they were evaluating. The prenatal environment, including both fetal development and placental adaptions, differs between males and females ([@c7]; [@c45]). We did not formally compare differences in outcomes between male and female offspring in this study, but potential sex-specific health implications of prenatal exposures to air pollutants on the risk of adverse pregnancy outcomes present an important subject for future research.

The short duration of ozone exposure was chosen to target the timing of the receptivity window for implantation in the rat, which occurs at approximately GD 5 to GD 6.75 ([@c55]). The suspected origin of some adverse pregnancy outcomes, including IUGR, is impaired implantation of the blastocyst into the uterine wall ([@c56]). According to accepted theory, blastocysts that do not implant at the correct depth and length can affect the ability of stem cells to form the placenta and engage in arterial remodeling. Our results suggest that implantation may be a critical time window for the effects of ambient ozone on IUGR, although we cannot rule out potential effects of exposure during other time periods. Our findings also support the value of our experimental model for the study of environmental pollutant effects on gestational outcomes in general. Epidemiological studies have reported associations between ambient air pollution exposures during early pregnancy and a variety of outcomes: for example, fetal growth parameters measured at 13--26 wk of gestation ([@c19]), preterm birth and preeclampsia ([@c38]), and placenta previa ([@c32]).

Average maternal serum FFA concentrations on GD 21 were higher in the exposed groups than in the controls in our study, consistent with findings from a case--control study reporting that serum FFAs at the time of cesarean section were higher in 24 women with IUGR pregnancies than in 30 women delivering term births by cesarean section and in 25 women at 35 wk gestation ([@c39]). The higher FFAs and lowered blood glucose in exposed dams compared with controls might be related to a prolonged stress response resulting in increased lipolytic capacity as an adaptive mechanism to raise FFA availability and glucose uptake in the fetus, as has been observed in studies of pregnant ewes ([@c22]). In the present study, we did not investigate the role of placental insufficiency in reducing fetal growth. In principle, disrupted implantation would also impair placental development. Thus, it is plausible that in this model, poor placental vascular development further compounded impaired uterine blood flow, resulting in reduced oxygen and nutrients available for development. In addition to assessing altered uterine blood flow, studies are in progress to determine if ozone exposure caused placental insufficiency and dysfunction in our model.

A previous study of mice exposed to urban air pollutants during the entirety of gestation reported that the maternal blood surface area and diameter in the placenta was reduced in exposed mice compared with controls ([@c53]). A recent study of diesel exhaust exposure throughout gestation in rabbits also reported reduced placental blood flow as measured by 3D Doppler ultrasound ([@c52]). Relatedly, a recent prospective cohort study of 366 pregnant women reported that ambient ozone exposure during the second trimester was associated with higher umbilical artery PI (greater vascular resistance), whereas exposure during the third trimester was associated with lower PI values ([@c8]). Together, these studies suggest the potential for gestational exposure to air pollutants to disrupt placental function, thus contributing to impaired fetal weight gain.

In otherwise healthy Long-Evans rats, ozone exposure exclusively during implantation was not associated with significant differences in renal pathology or markers of systemic inflammation in the dams at the end of gestation. Epidemiological findings have suggested that maternal ozone exposure may induce preeclampsia ([@c42]), a potentially fatal pregnancy disorder. Although we did not observe any signs of preeclampsia development in ozone-exposed dams (e.g., altered blood pressure, renal changes), it is important to note that the increased uterine arterial resistance observed in rats exposed to ozone during implantation is similar to that occurring in preeclamptic pregnancies and is indicative of impaired arterial remodeling. Uterine and spiral arterial remodeling are hypothesized to contribute to the etiology of preeclampsia ([@c56]).

Many of the cardiometabolic and pulmonary effects of acute ozone exposure in rodent models are believed to occur in part because of impaired respiration ([@c23]), induction of cardiac arrhythmia ([@c14]), glucose intolerance ([@c4]), and activation of the stress response ([@c24]). Because we did not monitor all of these end points, we cannot determine whether they contributed to associations between ozone exposure and fetal growth restriction at GD 21. In addition, we could not directly observe potential mechanisms linking ozone exposure to uterine arterial changes and reduced fetal weight on GD 21, but they may be related to ozone-induced endothelial dysfunction, as previously reported ([@c9]; [@c41]; [@c46]). The cardiometabolic and pulmonary effects induced by acute ozone exposure further complicate the identification of initiating mechanisms for the observed reduction in fetal weight; however, the findings presented here suggest an important interplay between the quality of implantation and alterations in arterial remodeling across gestation.

Conclusion {#s5}
==========

To our knowledge, we are the first to report experimental evidence that ozone exposure during early pregnancy may cause growth restriction in offspring. Our findings suggest that exposure during the period of implantation receptivity, which has a similar (approximately 2-d) duration in rats and humans, may cause diminished uterine artery flow later in gestation. Because 40,000,000 U.S. citizens reside in areas that are not in compliance with the NAAQS for ozone ([@c31]), the potential for adverse developmental consequences of ozone exposure has broad relevance for the health and well-being of infants and children.
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